Bonus Share Alert: Diagnostic Chain rewards shareholders despite recent underperformance

Shares of Metropolis Healthcare Ltd. are in focus on Thursday, February 5, after the company said its board has recommended and approved the bonus issue of equity shares in the 3:1 proportion.

This means shareholders will receive three fully paid-up equity shares of face value ₹2 each for every one fully-paid up equity share of the same face value held by shareholders as on the record date.

The record date for the same is yet to be announced. The bonus issue proposal is subject to the members', statutory and regulatory approvals, as applicable, the company said.

This will be Metropolis Health's first-ever bonus issue. The company has so far paid dividends worth ₹40 per share to its shareholders, starting 2020.

During the December quarter, Metropolis also reported a steady performance with strong revenue growth of 26% to ₹429.19 core in its third quarter. Its profit increased 32% to ₹52.67 crore.

Its patient and test volumes increased 14% and 13% from the previous year, respectively.

The TruHealth and Specialty portfolios recorded strong growth of 37% and 34%, respectively. Revenue per test increased 11%, while revenue per patient was up 10% from the previous year.

The company said its recent acquisitions have been integrated as planned.

Its core diagnostics segment reported stable margins.

Shares of Metropolis Healthcare ended the previous session 0.5% lower at ₹1,891.25 apiece. The stock has declined 7.8% in the past month. The stock was down 7% in 2025 as well. From its IPO price of ₹880, the stock is up nearly 120%.

Also Read: NHPC shares in focus after Q3 earnings miss, sharp fall in EBITDA, margins